Bernardo Nadal-Ginard

A researcher from Chestnut Hill, Massachusetts, Bernardo Nadal-Ginard, MD, PhD, has a career in the biological sciences dating back to the early 1970s. Prior to retiring, Dr. Bernardo Nadal-Ginard was a principal investigator (PI) and the CEO for Coretherapix a research company based in Madrid, Spain..

As a PI with Coretherapix, Dr. Nadal-Ginard obtained research grants of over 13 million euros (~15 million dollars), oversaw the design and execution of research projects and animal clinical trials, including their design, execution, and management. He planned the research protocol for studies, analyzed data generated from trials, and reported the results. He was also responsible for making sure that the trials complied with laws, regulations, and institutional policies.

Dr. Nadal-Ginard’s accomplishments include numerous articles published in peer-reviewed journals, books, and book chapters on topics in molecular and cellular biology, cardiology, and biological chemistry, among others. Over the years, he taught and engaged in research at esteemed institutions such as Albert Einstein College of Medicine, Harvard Medical Scholl, Boston Children’s Hospital, Magna Graecia University in Italy, New York Medical College, King’s College in London, Women’s Medical University in Tokyo.

Dr. Nadal-Ginard’s accomplishments garnered recognition for his contributions to research. Some of the awards include the Prize for Research from the Mexican Society of Cardiology (2006), Ramon Lull Prize for Science (2003) from the Autonomous Government of Balearic Islands in Spain, and the American Heart Association’s Basic Research Prize (1991), Doctor Honoris Causa from the Ba;earic University, Spain. He earned his PhD in biology from Yale University and medical degree from the University of Barcelona’s School of Medicine.